Back to Annual Meeting Page
133rd Annual Meeting & Exposition
December 10-14, 2005
Frances A. Stillman, EdD, Tobacco Control Research Program, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe Street, Baltimore, MD 21209, 443-287-6360, email@example.com
During the last decade, the idea that corporations should be viewed as being “good corporate citizens” or “give back to the community”, has gained prominence. Most companies now engage in some type of corporate social responsibility (CSR) or philanthropic activities. However, these CSR programs represent a wide range of activities done for many different reasons. CSR programs can do good but they can also do harm. In the case of the multinational Tobacco companies, research has found that the main reasons behind their programs (e.g., to support the homeless, aid Tsunami victims, and provide for support for the Arts), is the public relations value that these activities provide. In fact, these companies spent more money on advertising their good works than on the good works they were undertaking. Other companies, including the pharmaceutical industry, also engage in supporting scientific organizations and work closely with academics and other groups to promote policy development and service projects. This panel will present different aspects of CSR programs and provide a discussion of whether CSR programs can be good for public health.
Presenting author's disclosure statement:
I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.
The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA